Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome–Negative B-Cell Precursor …
P Chevallier, T Leguay, M Delord, C Salek… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE The use of inotuzumab ozogamicin (InO), a conjugated anti-CD22 monoclonal
antibody, is becoming a promising frontline treatment for older patients with ALL. PATIENTS …
antibody, is becoming a promising frontline treatment for older patients with ALL. PATIENTS …
Adsorption of thiotepa anticancer by the assistance of aluminum nitride nanocage scaffolds: A computational perspective on drug delivery applications
GGR Ortiz, B Cespedes-Panduro, I Saba… - Colloids and Surfaces A …, 2023 - Elsevier
This work was carried out by the importance of providing insights into the nano-based drug
delivery of anticancers. To this aim, a representative model of aluminum nitride (AN) …
delivery of anticancers. To this aim, a representative model of aluminum nitride (AN) …
[HTML][HTML] Thiotepa-based regimens are Valid Alternatives to total body irradiation-based reduced-intensity conditioning regimens in patients with Acute Lymphoblastic …
G Battipaglia, M Labopin, S Mielke, A Ruggeri… - … and Cellular Therapy, 2024 - Elsevier
Total body irradiation (TBI) at myeloablative doses is superior to chemotherapy-based
regimens in young patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic …
regimens in young patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic …
[HTML][HTML] Sequential Conditioning With FLAMSA Does Not Improve Outcomes of Allogeneic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia Patients
R Massoud, E Klyuchnikov, N Steiner, G Zeck… - … and Cellular Therapy, 2025 - Elsevier
As with myelodysplastic syndromes (MDS), effective treatment options for chronic
myelomonocytic leukemia (CMML) are limited, and the optimal treatment approach remains …
myelomonocytic leukemia (CMML) are limited, and the optimal treatment approach remains …
Thiotepa-busulfan-fludarabine conditioning as a promising approach prior to haploidentical allogeneic hematopoietic stem cell transplantation in hematological …
X Huang, X Wu, S Wang, Y Ren, Y Xu… - Leukemia …, 2024 - pubmed.ncbi.nlm.nih.gov
Thiotepa-busulfan-fludarabine conditioning as a promising approach prior to haploidentical
allogeneic hematopoietic stem cell transplantation in hematological malignancies with …
allogeneic hematopoietic stem cell transplantation in hematological malignancies with …
[引用][C] Adsorption of thiotepa anticancer by the assistance of aluminum nitride nanocage scaffolds: a computational perspective on drug delivery applications
B Céspedes Panduro, GG Reivan Ortiz, I Saba… - 2023 - Elsevier